- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
1997–2026 · program · P30
Bioinformatics Training Core
Shannan J Ho Sui · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Cancer Research and Training Coordination
Lee Marshall Nadler · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Community Outreach and Engagement
Kasisomayajula Viswanath · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 35: Melanoma
David E Fisher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 32: Gastrointestinal Malignancies
Brian Matthew Wolpin · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 32: Gastrointestinal Malignancies
Brian Matthew Wolpin · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2025 · program · P01
Targeted aberrant signaling in CBL-mutant leukemia
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 12: Developmental Therapeutics
Geoffrey I. Shapiro · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 15: Cancer Cell Biology
Kornelia Polyak · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 08 Cancer Data Sciences
Franziska Michor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 34: Lung Cancer
David A Barbie · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 60: Cancer Risk, Prevention, and Early Detection
Sapna Syngal · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P01
Targeted aberrant signaling in CBL-mutant leukemia
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 09: Rodent Histopathology
Peter M Howley · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Core 02: Cell Manipulation Core Facility
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 35: Melanoma
Frank S Hodi · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 10 Cancer Care Delivery Research
Deborah Schrag · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 10 Cancer Care Delivery Research
Jennifer W Mack · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 13: Cancer Risk and Disparities
Sapna Syngal · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 04 Cancer Proteomics
Towia A. Libermann · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Cancer Proteomics Core
Towia A. Libermann · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Rodent Histopathology Core
Peter M Howley · Dana-Farber Cancer Institute · funded by National Institutes of Health
1996–2025 · research · R37
Biochemical Mechanism of HIV DNA Integration
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1996–2024 · research · R01
Immunologic mechanisms that prevent autoimmunity
Harvey Cantor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1996–2025 · research · R37
Biochemical Mechanism of HIV DNA Integration
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1996–2022 · research · R01
Immunologic mechanisms that prevent autoimmunity
Harvey Cantor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1996–2025 · research · R37
Biochemical Mechanism of HIV DNA Integration
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1996–2025 · research · R37
Biochemical Mechanism of HIV DNA Integration
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1996–2022 · research · R01
Immunologic mechanisms that prevent autoimmunity
Harvey Cantor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1996–2022 · research · R01
Immunologic mechanisms that prevent autoimmunity
Harvey Cantor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1996–2025 · research · R37
Biochemical Mechanism of HIV DNA Integration
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1996–2022 · research · R01
Immunologic mechanisms that prevent autoimmunity
Harvey Cantor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1994–2027 · research · R01
Molecular Pathogenesis of Fanconi Anemia
Alan D. D'Andrea · Dana-Farber Cancer Institute · funded by National Institutes of Health
1994–2023 · research · R01
Molecular Pathogenesis of Fanconi Anemia
Alan D. D'Andrea · Dana-Farber Cancer Institute · funded by National Institutes of Health
1994–2023 · research · R01
Molecular Pathogenesis of Fanconi Anemia
Alan D. D'Andrea · Dana-Farber Cancer Institute · funded by National Institutes of Health
1994–2023 · research · R01
Molecular Pathogenesis of Fanconi Anemia
Alan D. D'Andrea · Dana-Farber Cancer Institute · funded by National Institutes of Health
1994–2023 · research · R01
Molecular Pathogenesis of Fanconi Anemia
Alan D. D'Andrea · Dana-Farber Cancer Institute · funded by National Institutes of Health
1994–2027 · research · R01
Molecular Pathogenesis of Fanconi Anemia
Alan D. D'Andrea · Dana-Farber Cancer Institute · funded by National Institutes of Health
1990–2024 · training · T32
Postdoctoral Training Program in AIDS-related Research
Harvey Cantor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1990–2025 · training · T32
Postdoctoral Training Program in AIDS-related Research
Harvey Cantor · Dana-Farber Cancer Institute · funded by National Institutes of Health
